Dysregulation of redox pathways in liver fibrosis

Research output: Contribution to journalReview article

22 Citations (Scopus)

Abstract

Reactive oxygen species are implicated in physiological signaling and cell fate decisions. In chronic liver diseases persistent and increased production of oxidative radicals drives a fibrogenic response that is a common feature of disease progression. Despite our understanding the biology of the main prooxidant enzymes, their targets, and antioxidant mechanisms in the liver, there is still lack of knowledge concerning their precise role in the pathogenesis of fibrosis. This review will examine the role of physiological redox signaling in the liver, provide an overview on recent advances in prooxidant and antioxidant pathways that are dysregulated during fibrosis, and highlight possible novel treatment targets.

Original languageEnglish (US)
Pages (from-to)G667-G674
JournalAmerican Journal of Physiology - Gastrointestinal and Liver Physiology
Volume311
Issue number4
DOIs
StatePublished - 2016

Fingerprint

Liver Cirrhosis
Oxidation-Reduction
Fibrosis
Antioxidants
Liver
Disease Progression
Liver Diseases
Reactive Oxygen Species
Chronic Disease
Enzymes

Keywords

  • Liver fibrosis
  • Oxidative stress
  • Redox signaling
  • Stellate cell activation

ASJC Scopus subject areas

  • Physiology
  • Hepatology
  • Gastroenterology
  • Physiology (medical)

Cite this

Dysregulation of redox pathways in liver fibrosis. / Torok, Natalia J.

In: American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 311, No. 4, 2016, p. G667-G674.

Research output: Contribution to journalReview article

@article{966759ca269149b1bc2faf723bb1915b,
title = "Dysregulation of redox pathways in liver fibrosis",
abstract = "Reactive oxygen species are implicated in physiological signaling and cell fate decisions. In chronic liver diseases persistent and increased production of oxidative radicals drives a fibrogenic response that is a common feature of disease progression. Despite our understanding the biology of the main prooxidant enzymes, their targets, and antioxidant mechanisms in the liver, there is still lack of knowledge concerning their precise role in the pathogenesis of fibrosis. This review will examine the role of physiological redox signaling in the liver, provide an overview on recent advances in prooxidant and antioxidant pathways that are dysregulated during fibrosis, and highlight possible novel treatment targets.",
keywords = "Liver fibrosis, Oxidative stress, Redox signaling, Stellate cell activation",
author = "Torok, {Natalia J}",
year = "2016",
doi = "10.1152/ajpgi.00050.2016",
language = "English (US)",
volume = "311",
pages = "G667--G674",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "4",

}

TY - JOUR

T1 - Dysregulation of redox pathways in liver fibrosis

AU - Torok, Natalia J

PY - 2016

Y1 - 2016

N2 - Reactive oxygen species are implicated in physiological signaling and cell fate decisions. In chronic liver diseases persistent and increased production of oxidative radicals drives a fibrogenic response that is a common feature of disease progression. Despite our understanding the biology of the main prooxidant enzymes, their targets, and antioxidant mechanisms in the liver, there is still lack of knowledge concerning their precise role in the pathogenesis of fibrosis. This review will examine the role of physiological redox signaling in the liver, provide an overview on recent advances in prooxidant and antioxidant pathways that are dysregulated during fibrosis, and highlight possible novel treatment targets.

AB - Reactive oxygen species are implicated in physiological signaling and cell fate decisions. In chronic liver diseases persistent and increased production of oxidative radicals drives a fibrogenic response that is a common feature of disease progression. Despite our understanding the biology of the main prooxidant enzymes, their targets, and antioxidant mechanisms in the liver, there is still lack of knowledge concerning their precise role in the pathogenesis of fibrosis. This review will examine the role of physiological redox signaling in the liver, provide an overview on recent advances in prooxidant and antioxidant pathways that are dysregulated during fibrosis, and highlight possible novel treatment targets.

KW - Liver fibrosis

KW - Oxidative stress

KW - Redox signaling

KW - Stellate cell activation

UR - http://www.scopus.com/inward/record.url?scp=84990922140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990922140&partnerID=8YFLogxK

U2 - 10.1152/ajpgi.00050.2016

DO - 10.1152/ajpgi.00050.2016

M3 - Review article

C2 - 27562057

AN - SCOPUS:84990922140

VL - 311

SP - G667-G674

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 4

ER -